Jin C - Search Results

1

Women and girls with haemophilia: A retrospective cohort study in China.

Zhang W, Li K, Poon MC, Zhang X, Wu J, Zhao X, Zhou M, Wang X, Zhang M, Xu W, Yang L, Huang M, Jin C, Wang X, Zhang D, Chen L, Liu W, Zhang L, Xue F, Yang R. Zhang W, et al. Among authors: jin c. Haemophilia. 2023 Mar;29(2):578-590. doi: 10.1111/hae.14740. Epub 2023 Jan 3. Haemophilia. 2023. PMID: 36595620

2

Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies.

Yang R, Zhao Y, Wang X, Sun J, Wu R, Jin C, Jin J, Wu D, Rendo P, Sun F, Rupon J, Huard F, Korth-Bradley JM, Xu L, Luo B, Liu YC. Yang R, et al. Among authors: jin c, jin j. J Blood Med. 2020 Nov 25;11:439-448. doi: 10.2147/JBM.S241605. eCollection 2020. J Blood Med. 2020. PMID: 33269010 Free PMC article.

3

Efficacy, safety and bioequivalence of the human-derived B-domain-deleted recombinant factor VIII TQG202 for prophylaxis in severe haemophilia A patients.

Xi Y, Jin C, Liu W, Zhou H, Wang Z, Zhou R, Lou S, Zhao X, Chen F, Cheng P, Sun Z, Jia H, Zhang L. Xi Y, et al. Among authors: jin c. Haemophilia. 2022 Nov;28(6):e219-e227. doi: 10.1111/hae.14652. Epub 2022 Aug 22. Haemophilia. 2022. PMID: 35996199 Free PMC article. Clinical Trial.

4

Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China.

Dou X, Zhang W, Poon MC, Zhang X, Wu R, Feng X, Yang L, Cheng P, Chen S, Wang Y, Zhou H, Huang M, Song Y, Jin C, Zhang D, Chen L, Liu W, Zhang L, Xue F, Yang R. Dou X, et al. Among authors: jin c. Haemophilia. 2023 Jan;29(1):123-134. doi: 10.1111/hae.14665. Epub 2022 Sep 26. Haemophilia. 2023. PMID: 36163649

5

Efficacy and safety of the B-domain-deleted TQG202 for on-demand treatment in moderate and severe haemophilia A patients: A multicentre, single-arm trial.

Sun Z, Xi Y, Liu W, Yang L, Wang X, Jin C, Jia H, Zhang L. Sun Z, et al. Among authors: jin c. Haemophilia. 2023 Jul;29(4):997-1004. doi: 10.1111/hae.14777. Epub 2023 Mar 13. Haemophilia. 2023. PMID: 36913439 Clinical Trial.

6

Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.

Zhang Y, Zhou H, Jiang Z, Wu D, Zhuang J, Li W, Jiang Q, Wang X, Huang J, Zhu H, Yang L, Du X, Li F, Xia R, Zhang F, Hu J, Li Y, Hu Y, Liu J, Jin C, Sun K, Zhou Z, Wu L, Yu W, Jin J. Zhang Y, et al. Among authors: jin c, jin j. Am J Hematol. 2022 Dec;97(12):1510-1519. doi: 10.1002/ajh.26709. Epub 2022 Oct 4. Am J Hematol. 2022. PMID: 36054786 Free PMC article. Clinical Trial.

7

Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.

Zhang Y, Zhou H, Jiang Z, Wu D, Zhuang J, Li W, Jiang Q, Wang X, Huang J, Zhu H, Yang L, Du X, Li F, Xia R, Zhang F, Hu J, Li Y, Hu Y, Liu J, Jin C, Sun K, Zhou Z, Wu L, Yin H, Suo S, Yu W, Jin J. Zhang Y, et al. Among authors: jin c, jin j. Am J Hematol. 2024 Apr;99(4):774-779. doi: 10.1002/ajh.27245. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343062 Clinical Trial.

8

[Dosage and curative effect of blood coagulation factor VIII in the prevention and treatment of haemophilia A in children].

Wei Y, Huang Y, Zhai B, Yu J, Wan C, Liu T, Jin C, Cheng H. Wei Y, et al. Among authors: jin c. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Aug;39(8):831-4. doi: 10.3969/j.issn.1672-7347.2014.08.013. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25202961 Free article. Chinese.

9

Platelet and peripheral white blood cell counts at diagnosis predict the response of adult immune thrombocytopenia to recombinant human interleukin-11: A retrospective, single-center, case-control study.

Jin C, Wang Y, Cheng H, Liu H, Liu T, Ke B, Li A, Yang L, Zhu Q, Ding W, Luo M, Wei Y, Kong C. Jin C, et al. Medicine (Baltimore). 2019 Apr;98(16):e15195. doi: 10.1097/MD.0000000000015195. Medicine (Baltimore). 2019. PMID: 31008943 Free PMC article.

10

Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional Mendelian randomization study.

Qin J, Zhang L, Ke B, Liu T, Kong C, Jin C. Qin J, et al. Among authors: jin c. Front Immunol. 2023 Sep 11;14:1248325. doi: 10.3389/fimmu.2023.1248325. eCollection 2023. Front Immunol. 2023. PMID: 37753071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,091 results

Search Page